Here’s What Analysts Had to Say About These Trending Stocks

Page 1 of 2

Although they may not be right all of the time, analysts on the Street often have a lot more information than the average investor. The sell-side can also have a strong impact on the short-term price of many securities. Given that, we pay close attention to the latest analyst calls and commentary and have put together a list of that action from the past trading week as it relates to five prominent stocks, CSX Corporation (NASDAQ:CSX), Endo International plc – Ordinary Shares (NASDAQ:ENDP), Netflix, Inc. (NASDAQ:NFLX), Tractor Supply Company (NASDAQ:TSCO), and Intel Corporation (NASDAQ:INTC).

Let’s dive in and see what various analysts had to say about the five stocks, in addition to checking out the latest 13F data to determine how hedge funds are trading these stocks.

We believe that imitating hedge funds and other large institutional investors can be helpful in identifying stocks capable of outperforming the broader market. Through extensive research that covered portfolios of several hundred large investors between 1999 and 2012, we determined that following the small-cap stocks that large money managers are collectively bullish on, can generate monthly returns nearly 1.0 percentage points above the market (see the details here).


CSX Corporation (NASDAQ:CSX) received a thumbs up from Stephens’ Justin Long, who raised his price target on the stock to $37 from $32 and maintained his ‘Overweight’ rating  on it. Mr. Long likes how CSX has noticeably improved its operating leverage and notes that CSX will soon head into a period of more favorable year-over-year comps. If commodity prices normalize, CSX could also benefit further in the long run. Paul Marshall and Ian Wace’s Marshall Wace LLP raised its stake in CSX Corporation (NASDAQ:CSX) by 21% in the second quarter to 2.97 million shares as of the end of June.

Follow Csx Corp (NYSE:CSX)

Endo International plc – Ordinary Shares (NASDAQ:ENDP) shares inched up on Friday after Louise Chen of Guggenheim expounded on her ‘Buy’ recommendation and $35 price target. According to her sum-of-parts calculations, Chen estimates that Endo is worth anywhere between $30 and $51 per share, or 50%-to-150% higher than its current price. Chen thinks Endo’s management could send the price up by 50% or more if they choose to divest some of their non-core assets and Endo’s brand business to unlock value. 36 funds that we track owned shares of Endo International plc – Ordinary Shares (NASDAQ:ENDP) at the end of the second quarter, a slide of 13 funds from a quarter earlier.

Follow Endo Health Solutions Inc. (NASDAQ:ENDP)

On the next page we’ll see what analysts had to say about Netflix, Tractor Supply Company, and Intel this week.

Page 1 of 2